GRP
DMAC icon

Global Retirement Partners’s DiaMedica Therapeutics DMAC Stock Holding History

Global Retirement Partners’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.03K Buy
+130
New +$972 ﹤0.01% 3881

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Global Retirement Partners's DMAC Position: Q4 2025 in Review

Global Retirement Partners opened a new position in DiaMedica Therapeutics (DMAC) in Q4 2025: 130 shares worth $1.03K. The stake represents ﹤0.01% of the portfolio and ranks #3881 among its holdings.

92 funds tracked by Wall St. Rank hold DMAC as of Q4 2025.

  • Global Retirement Partners held 130 shares of DiaMedica Therapeutics worth $1.03K as of Q4 2025.
  • DiaMedica Therapeutics was a new Global Retirement Partners position in Q4 2025.
  • DiaMedica Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3881 holding.
  • 92 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.